A multicenter retrospective study on the efficacy and safety of fosravuconazole in patients with onychomycosis-Reference-Cited by-同舟云学术

A multicenter retrospective study on the efficacy and safety of fosravuconazole in patients with onychomycosis

Author:

Noguchi Hiromitsu¹,Naka Wataru²,Nishio Kazunori³,Matsuda Tetsuo⁴,Nakano Makoto⁵,Hiruma Masataro⁶

Affiliation:

1. Noguchi Dermatology Clinic

2. Naka Dermatology Clinic

3. Koujiya Dermatology Clinic

4. Matsuda Dermatology Clinic

5. Sato Pharmaceutical Co., Ltd.

6. Hiruma Dermatology & Otorhinolaryngology Clinic

Publisher

Japan Organization of Clinical Dermatologists

Subject

Education,Cultural Studies

Link

Reference12 articles.

1. 仲　弥ほか：足白癬・爪白癬の実態と潜在罹患率の大規模疫学調査(Foot Check 2007).日臨皮会誌 2009; 26: 27-36.

2. 望月　隆ほか：日本皮膚科学会皮膚真菌症診療ガイドライン2019. 日皮会誌 2019; 129: 2639-2673.

3. 原田和俊ほか：爪白癬患者の治療継続に関するインターネットを使った意識調査. 日臨皮会誌 2019; 36: 602-611.

4. 山口英世：新規経口爪白癬治療薬ホスラブコナゾールL‐リシンエタノール付加物(ホスラブコナゾール)の薬理学的特徴と臨床的有用性. Jpn J Antibiot 2019; 72: 187-207.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献